AIM
ENTA icon

Aigen Investment Management’s Enanta Pharmaceuticals ENTA Stock Holding History

Aigen Investment Management’s Portfolio ENTA Stock Details ENTA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-6,987
Closed -$307K – 529
2021
Q2 		$307K Sell
6,987
-1,299
-16% -$63.6K 0.05% 328
2021
Q1 		$409K Sell
8,286
-4,568
-36% -$228K 0.05% 339
2020
Q4 		$541K Buy
12,854
+2,522
+24% +$111K 0.07% 369
2020
Q3 		$473K Sell
10,332
-279
-3% -$13.5K 0.06% 409
2020
Q2 		$533K Sell
10,611
-13,821
-57% -$715K 0.07% 434
2020
Q1 		$1.26M Buy
24,432
+20,217
+480% +$1.08M 0.17% 163
2019
Q4 		$260K Buy
+4,215
New +$261K 0.04% 479

Other funds holding ENTA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
First Manhattan
First Manhattan New York $36.1B AUM 11.5% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
KAM
Krensavage Asset Management New York $256M AUM 69.63% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Aigen Investment Management's ENTA Position: Q3 2021 in Review

Aigen Investment Management sold out of Enanta Pharmaceuticals (ENTA) in Q3 2021, closing a stake of 6,987 shares — an estimated $307K sold.

Aigen Investment Management first reported a position in ENTA in Q4 2019 and held it in 7 quarters. The position peaked at $1.26M in Q1 2020. 147 funds tracked by Wall St. Rank hold ENTA as of Q3 2021.

  • Aigen Investment Management reported no remaining Enanta Pharmaceuticals position as of Q3 2021 after selling out during the quarter.
  • Aigen Investment Management sold 6,987 Enanta Pharmaceuticals shares in Q3 2021, an estimated $307K.
  • Aigen Investment Management first reported a position in Enanta Pharmaceuticals in Q4 2019 and held it in 7 quarters.
  • Aigen Investment Management's Enanta Pharmaceuticals position peaked at $1.26M in Q1 2020.
  • 147 funds tracked by Wall St. Rank held Enanta Pharmaceuticals as of Q3 2021.

Based on Aigen Investment Management's 13F filing for Q3 2021, filed 12 Nov 2021.